Potentiation of biological effects of mesenchymal stem cells in ischemic conditions by melatonin via upregulation of cellular prion protein expression

In conclusion, melatonin‐treated MSCs could provide a therapeutic strategy for vessel regeneration in ischemic disease, and the targeting of PrPC levels may prove instrumental for MSC‐based therapies. This article is protected by copyright. All rights reserved.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fjpi.12385

Source: Journal of Pineal Research - January 16, 2017 Category: Research Authors: Jun Hee Lee, Yong ‐Seok Han, Sang Hun Lee Tags: Original Article Source Type: research